Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • Sealzad
    Junior Member
    • Feb 2018
    • 6

    #1

    Understanding sailfish-cir results

    Hi, I have a problem trying to understand/interpret the results of the sailfish-cir. I went through the manual and article a few times, but I still don't fully grasp the interpretation of it.

    Supposedly I saw a putative back splice junction (BSJ) coordinate produced by CIRI (circular RNA identifier by Gao et al (2015)) - chr17:43057051|43115779 - corresponding to BRCA1. Sailfish-cir will generate a TPM value for the said coordinate as well. And from my understanding of the article (and the developer), the value is actually a proportion of circRNA and linear transcripts. However, sailfish-cir also produces TPM values pertaining to the transcript IDs of BRCA1. I.e., There is a fair chance that all of the transcript IDs related to BRCA1 would should a TPM value.

    So my question are:

    1) How should I go about interpreting the information? Should I see TPMs that are related to BRCA1 or only for the BSJ's? 2) Is the TPM for BSJ only for BSJ? 3) Is the TPM for transcript IDs only for respective transcript? 4) If I want to know how does the expression of circRNA (i.e., the BSJ's) is presenting, how should I go about analyzing it? 5) Supposedly points 2 & 3 are true, is the ratio of circRNA suppose to be calculated as (BSJ) / (BSJ + transcript ID)?

    Hope someone can help clarify these confusion. Thank you.

Latest Articles

Collapse

  • SEQadmin2
    Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
    by SEQadmin2



    CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

    Despite this, “CRISPR helped turn genome editing from a specialized technique into
    ...
    07-31-2026, 11:01 AM
  • SEQadmin2
    Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
    by SEQadmin2


    Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

    The systematic characterization of the human proteome has
    ...
    07-20-2026, 11:48 AM
  • SEQadmin2
    Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
    by SEQadmin2



    Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
    ...
    07-09-2026, 11:10 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, Today, 07:41 AM
0 responses
8 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 08-03-2026, 10:13 AM
0 responses
21 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-31-2026, 02:55 AM
0 responses
35 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-24-2026, 12:17 PM
0 responses
25 views
0 reactions
Last Post SEQadmin2  
Working...